Safety and Efficacy Comparison of TG-873870(Nemonoxacin) to Levofloxacin in Community-Acquired Pneumonia

NCT00434291 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

264

Enrollment

INDUSTRY

Sponsor class

Conditions

Community-Acquired Pneumonia

Interventions

DRUG: TG-873870(Nemonoxacin)

Sponsor

TaiGen Biotechnology Co., Ltd.

Collaborators

[object Object]